Clinical trials back its use in reducing belly fat and it may aid in overall body contouring ahead of surgery
First isolated from human plasma albumin by Loren Pickart in 1973, GHK-Cu has been studied for its roles in wound healing, tissue remodeling, anti-inflammatory effects, and gene expression modulation
Researchers utilize GHK-Cu as a reference compound for studies in extracellular matrix remodeling, copper bioavailability, lysyl oxidase (LOX) activation, and metallopeptide signaling
Due to epithalons proven ability to induce telomerase activity and suppress CCl11 and HMGB1 genes, with the effect of increasing the lifespan of human somatic cells, many researchers view it as an anti-aging compound [2]
Researchers became interested in this combination because early studies suggested that adding amylin pathway modulation to triple incretin agonism could produce synergistic effects beyond either component alone similar to how the CagriSema (cagrilintide + GLP1) combination outperformed individual components in clinical trials